Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia
Background<br/> Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine...
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Journal article |
| 出版事項: |
BioMed Central
2018
|